Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation
Mohamed A. Kharfan‐Dabaja, Hillard M. Lazarus, Taiga Nishihori, et al.
Biology of Blood and Marrow Transplantation (2013) Vol. 19, Iss. 7, pp. 1006-1012
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients
Arthur E. Frankel, Jung Hee Woo, Chul Ahn, et al.
Blood (2014) Vol. 124, Iss. 3, pp. 385-392
Open Access | Times Cited: 215
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches
Livio Pagano, Caterina Giovanna Valentini, Sara Grammatico, et al.
British Journal of Haematology (2016) Vol. 174, Iss. 2, pp. 188-202
Open Access | Times Cited: 179
A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates
Gurunadh R. Chichili, Ling Huang, Hua Li, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 289
Closed Access | Times Cited: 158
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm
Tomohiro Aoki, Ritsuro Suzuki, Yachiyo Kuwatsuka, et al.
Blood (2015) Vol. 125, Iss. 23, pp. 3559-3562
Open Access | Times Cited: 124
Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
Maria Rosaria Sapienza, Alessandro Pileri, Enrico Derenzini, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 595-595
Open Access | Times Cited: 111
Extramedullary Manifestations of Myeloid Neoplasms
Carla S. Wilson, L. Jeffrey Medeiros
American Journal of Clinical Pathology (2015) Vol. 144, Iss. 2, pp. 219-239
Open Access | Times Cited: 110
Treatment of blastic plasmacytoid dendritic cell neoplasm
Jill M. Sullivan, David A. Rizzieri
Hematology (2016) Vol. 2016, Iss. 1, pp. 16-23
Open Access | Times Cited: 92
Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm
Albrecht Stenzinger, Volker Endris, Nicole Pfarr, et al.
Oncotarget (2014) Vol. 5, Iss. 15, pp. 6404-6413
Open Access | Times Cited: 90
Blastic Plasmacytoid Dendritic Cell Neoplasm: Update on Molecular Biology, Diagnosis, and Therapy
Wasif Riaz, Ling Zhang, Pedro Horna, et al.
Cancer Control (2014) Vol. 21, Iss. 4, pp. 279-289
Open Access | Times Cited: 81
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study
Mohamed A. Kharfan‐Dabaja, Monzr M. Al Malki, Uday Deotare, et al.
British Journal of Haematology (2017) Vol. 179, Iss. 5, pp. 781-789
Open Access | Times Cited: 71
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy
Uday Deotare, Karen Yee, Lisa W. Le, et al.
American Journal of Hematology (2015) Vol. 91, Iss. 3, pp. 283-286
Open Access | Times Cited: 68
Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm
Naveen Pemmaraju, Marina Konopleva
Blood Advances (2020) Vol. 4, Iss. 16, pp. 4020-4027
Open Access | Times Cited: 58
Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients
Kamel Laribi, Alix Baugier de Materre, Mohamad Sobh, et al.
Blood Advances (2020) Vol. 4, Iss. 19, pp. 4838-4848
Open Access | Times Cited: 58
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Naveen Pemmaraju, Kendra Sweet, Anthony S. Stein, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 26, pp. 3032-3036
Open Access | Times Cited: 32
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 31
T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia
Armen Mardiros, Stephen J. Forman, Lihua E. Budde
Current Opinion in Hematology (2015) Vol. 22, Iss. 6, pp. 484-488
Open Access | Times Cited: 52
Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
Laure Philippe, Adam Ceroi, Elodie Bôle‐Richard, et al.
Haematologica (2017) Vol. 102, Iss. 11, pp. 1861-1868
Open Access | Times Cited: 43
Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment
Kendra Sweet
Current Opinion in Hematology (2020) Vol. 27, Iss. 2, pp. 103-107
Closed Access | Times Cited: 37
CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm
Elodie Bôle‐Richard, Maxime Fredon, Sabeha Biichlé, et al.
Leukemia (2020) Vol. 34, Iss. 12, pp. 3228-3241
Closed Access | Times Cited: 36
Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy
Nathaniel R. Wilson, Marina Konopleva, Joseph D. Khoury, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 21, Iss. 11, pp. 734-740
Closed Access | Times Cited: 29
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
Hemant S. Murthy, Mei‐Jie Zhang, Karen Chen, et al.
Blood Advances (2023) Vol. 7, Iss. 22, pp. 7007-7016
Open Access | Times Cited: 12
Allogeneic Hematopoietic Cell Transplantation Is an Effective Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm in First Complete Remission: Systematic Review and Meta-analysis
Mohamed A. Kharfan‐Dabaja, Tea Reljic, Hemant S. Murthy, et al.
Clinical Lymphoma Myeloma & Leukemia (2018) Vol. 18, Iss. 11, pp. 703-709.e1
Closed Access | Times Cited: 34
Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation
Fatima Hamadeh, Amad Awadallah, Howard Meyerson, et al.
Cytometry Part B Clinical Cytometry (2019) Vol. 98, Iss. 1, pp. 43-51
Open Access | Times Cited: 32
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics
Ijele Adimora, Nathaniel R. Wilson, Naveen Pemmaraju
Cancer (2022) Vol. 128, Iss. 16, pp. 3019-3026
Closed Access | Times Cited: 17
Venetoclax and hypomethylating agents versus tagraxofusp in older patients with blastic plasmacytoid dendritic cell neoplasm
Benjamin J. Lee
Annals of Hematology (2025)
Open Access
Page 1 - Next Page

Scroll to top